Understanding the risk of NMS in young patients

A new study in the peer-reviewed Journal of Child and Adolescent Psychopharmacology estimated the incidence of neuroleptic malignant syndrome (NMS), a potentially fatal adverse effect of antipsychotic treatment, among individuals ages 5-24 years.

AstraZeneca to build $1.5bn ADC production facility in Singapore

The ADC manufacturing facility in Singapore is set to enhance global cancer treatment supply. Credit: Volodymyr Horbovyy / Shutterstock.com. AstraZeneca is set to invest $1.5bn

May 21, 2024

Phil Donahue dies: Pioneering daytime talk show host who launched an indelible television genre was 88 – The Cannabist

Phil Donahue, whose pioneering daytime talk show launched an indelible television genre that brought success to Oprah Winfrey, Montel Williams, Ellen DeGeneres and many others,

August 19, 2024

Pioneering protocol sheds light on NMDA receptor distribution in Alzheimer’s brains

Researchers from the Institute for Neurosciences (IN), a joint center of the Miguel Hernández University of Elche (UMH) and the Spanish National Research Council (CSIC),

November 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.